Optimizing evaluation of Lissamine Green parameters for ocular surface staining

Eye

Volumn 25, Issue 11, 2011, Pages 1429-1434

  Hamrah, P ^a,b   Alipour, F ^b   Jiang, S ^a   Sohn, J H ^a   Foulks, G N ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

conjunctiva; corneal staining; dry eye; Lissamine Green; ocular surface; vital dye

Indexed keywords

DYE; KITON GREEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DISEASE SEVERITY; DRY EYE; EYE EXAMINATION; FEMALE; HUMAN; INTERRATER RELIABILITY; MALE; OCULAR SURFACE STAINING; PROSPECTIVE STUDY; RATING SCALE; STAINING; TOTAL QUALITY MANAGEMENT;

EID: 80955123626     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.184     Document Type: Article

References (20)

1. Kim J. The use of vital dyes in corneal disease. Curr Opin Ophthalmol 2000; 11: 241-247. (Pubitemid 30490801)
2. Chodosh J, Dix RD, Howell RC, Stroop WG, Tseng SC. Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B. Invest Ophthalmol Vis Sci 1994; 35: 1046-1058. (Pubitemid 24079837)
3. Manning FJ, Wehrly SR, Foulks GN. Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology 1995; 102: 1953-1957. (Pubitemid 26004620)
4. Brooks SE, Kaza V, Nakamura T, Trousdale MD. Photoinactivation of herpes simplex virus by rose bengal and fluorescein. In vitro and in vivo studies. Cornea 1994; 13: 43-50. (Pubitemid 24014598)
5. Feenstra RP, Tseng SC. What is actually stained by rose bengal? Arch Ophthalmol 1992; 110: 984-993.
6. Lee YC, Park CK, Kim MS, Kim JH. In vitro study for staining and toxicity of rose bengal on cultured bovine corneal endothelial cells. Cornea 1996; 15: 376-385. (Pubitemid 26189978)
7. Lemp MA, Bron AJ, Baudouin C, Del Castillo JM, Geffen D, Tauber J et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011; 1(5): 792-798.e1.
8. Versura P, Frigato M, Cellini M, Mule R, Malavolta N, Campos EC. Diagnostic performance of tear function tests in Sjogrens syndrome patients. Eye (Lond) 2007; 21(2): 229-237 (Pubitemid 46454603)
9. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007; 5: 108-152.
10. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003; 22: 640-650. (Pubitemid 37175145)
11. Foulks GN. Challenges and pitfalls in clinical trials of therapy of dry eye. Ocul Surf 2003; 1: 20-30 (Pubitemid 41263854)
12. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007; 575-592.
13. Conn HJ. Biological Stains. Williams & Wilkins, Co.: Baltimore, 1961.
14. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008; 126: 219-225. (Pubitemid 351240851)
15. Weber J, Keating GM. Cevimeline. Drugs 2008; 68: 1691-1698.
16. Peral A, Dominguez-Godinez CO, Carracedo G, Pintor J. Therapeutic targets in dry eye syndrome. Drug News Perspect 2008; 21: 166-176. (Pubitemid 351809140)
17. Pinheiro Jr MN, dos Santos PM, dos Santos RC, Barros Jde N, Passos LF, Cardoso Neto J. Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögrens syndrome patients. Arq Bras Oftalmol 2007; 70: 649-655
18. Research in dry eye: report of the Research Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007; 5: 179-193.
19. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004; 23: 272-285 (Pubitemid 38404279)
20. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007; 5: 163-178.